DUBAI-MEDIA-CITY
The winners of the UAE Young Lions Competition were announced today at an event hosted by Dubai Media City (DMC) . The winning team, Gabriel Noguiera de Gama and Guilherme Aguir Grossi from TBWA/RAAD, will represent the UAE at the Cannes Lions International Festival of Creativity in June 2015, with the chance to win the highly coveted Young Lions Award.
The UAE Young Lions Competition, held in partnership with DMC, is part of the Cannes Lions International Festival of Creativity, the world’s largest awards ceremony celebrating creativity, which brings together 12,000 people from 94 countries for a week-long programme of talks, workshops and academies to ignite creativity and innovation. Motivate along with Motivate Val Morgan have been the official representatives of the Cannes Young Lions Festival for over 17 years, in association with DMC.
The competition saw 16 teams take part, who were given 24 hours to create a campaign for Beat Diabetes, an initiative by the Landmark Group. This year, the competition took the format of a cyber-competition, and entrants were invited to submit their campaigns via social media platforms (Facebook, YouTube and Instagram).
Speaking after the event, Mohammad Abdullah, Managing Director of TECOM’s Media Cluster, said:
“Dubai Media City has been the main partner for the UAE Young Lions Competition for more than five years, and we are delighted that today’s winning team will have the opportunity to showcase their creativity in Cannes next month. The Young Lions Award is a very prestigious prize, and the Cannes International Festival of Creativity is an excellent platform to connect some of the world’s most creative talent. The UAE has a track record of success at the festival, and I am confident that this year’s winners will continue this tradition.”
Ian Fairservice, Managing Partner, Motivate Group, said:
“Having hosted this competition for years, we are pleased to be able to give so many young creatives the opportunity to compete for a place in the team that will represent the UAE in Cannes. We replicate the exact environment in which the competition is held in Cannes so that our winners have the best possible chance of success when competing there against teams from around the world.”
The silver prize was awarded to Sarah Mamlouk and Anika Marya from Saatchi & Saatchi, and bronze to Nadia Alken and Adam Fierman from J. Walter Thompson.
About Dubai Media City
Dubai Media City (DMC), part of TECOM Investments, a member of Dubai Holding is an established and thriving business community that is home to leading local, regional and international media companies, and provides a dynamic and creative environment to its business partners. DMC offers a range of real estate products such as boutique offices, business centres and loft offices to best suit its business partners’ needs, and since its inauguration in 2001, has grown to become a thriving business hub, home to leading international and regional brands including CNN, Thomson Reuters and MBC. DMC offers state-of-the-art infrastructure which supports the current and future needs of business partners, and businesses of all sizes can operate alongside leading local, regional and international players. DMC is an ecosystem for the industry, and through networking events, business partners can share ideas and access industry experts and other business partners.
For more information visit www.dubaimediacity.com / www.tecom.ae
*Source: ME NewsWire
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150506005904/en/
Contact:
for Dubai Media City
Alexa Hooft Graafland, +971-555-597-404
AHooftGraafland@bell-pottinger.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
SBC Medical added to membership of Russell 3000® Index28.6.2025 01:30:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to
Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 22:44:00 CEST | Press release
Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further
Andersen Consulting udvider sine kompetencer inden for forretningstransformation med tilføjelsen af The Clearing27.6.2025 16:48:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin platform med samarbejdsfirmaet The Clearing, som er en managementkonsulentvirksomhed med speciale i organisatorisk omstilling og lederudvikling. The Clearing blev stiftet i 2009 og rådgiver kunder om komplekse udfordringer ved at afstemme ledelse, strategi, kultur og drift. Firmaet arbejder med føderale agenturer, virksomheder og nonprofitorganisationer med henblik på at skabe målbare forandringer på tværs af forskellige interessenter til gavn for en leders vision og strategi. Med dyb erfaring inden for flere sektorer, herunder national sikkerhed, sundhedspleje og finansielle tjenester, leder The Clearings unikke blanding af talent med ekspertise inden for organisationsudvikling, dataanalyse og visuel rådgivning forretningstransformationer i stor skala og arbejder sammen med kunder og eksperter for at sikre, at rådgivning omsættes til implementering. "Vi leverer transformative resultater, der ikke kun er i overensstemmelse med strategiske mål, men også
PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 16:00:00 CEST | Press release
PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu
STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries27.6.2025 14:00:00 CEST | Press release
New instrument automates tissue processing for researchers in cancer, immunology and other science fields To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627342791/en/ To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum